Commonwealth Equity Services’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Sell |
90,672
-1,358
| -1% | -$1.81K | ﹤0.01% | 4031 |
|
|
2025
Q1 | $110K | Buy |
92,030
+14,305
| +18% | +$17.1K | ﹤0.01% | 3975 |
|
|
2024
Q4 | $127K | Sell |
77,725
-672
| -0.9% | -$1.1K | ﹤0.01% | 3865 |
|
|
2024
Q3 | $299K | Sell |
78,397
-530
| -0.7% | -$2.02K | ﹤0.01% | 3356 |
|
|
2024
Q2 | $231K | Sell |
78,927
-930
| -1% | -$2.72K | ﹤0.01% | 3532 |
|
|
2024
Q1 | $316K | Buy |
79,857
+2,850
| +4% | +$11.3K | ﹤0.01% | 3225 |
|
|
2023
Q4 | $383K | Buy |
77,007
+10,429
| +16% | +$51.9K | ﹤0.01% | 2957 |
|
|
2023
Q3 | $336K | Buy |
66,578
+3,025
| +5% | +$15.3K | ﹤0.01% | 2925 |
|
|
2023
Q2 | $320K | Buy |
63,553
+2,503
| +4% | +$12.6K | ﹤0.01% | 2996 |
|
|
2023
Q1 | $375 | Buy |
61,050
+50
| +0.1% | – | ﹤0.01% | 2788 |
|
|
2022
Q4 | $805K | Buy |
61,000
+100
| +0.2% | +$1.32K | ﹤0.01% | 2106 |
|
|
2022
Q3 | $180K | Buy |
60,900
+2,440
| +4% | +$7.21K | ﹤0.01% | 3219 |
|
|
2022
Q2 | $213K | Buy |
58,460
+5,085
| +10% | +$18.5K | ﹤0.01% | 3141 |
|
|
2022
Q1 | $330K | Buy |
53,375
+4,300
| +9% | +$26.6K | ﹤0.01% | 2891 |
|
|
2021
Q4 | $397K | Buy |
49,075
+32,955
| +204% | +$267K | ﹤0.01% | 2725 |
|
|
2021
Q3 | $240K | Buy |
+16,120
| New | +$240K | ﹤0.01% | 3117 |
|